Michael R Bishop Selected Research

Michael R Bishop Research Topics

Disease

39	Neoplasms (Cancer) 12/2021 - 04/2003
14	Lymphoma (Lymphomas) 01/2022 - 03/2003
13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 03/2003
12	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 03/2004
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 11/2012
7	Leukemia 01/2018 - 02/2004
7	Breast Neoplasms (Breast Cancer) 08/2009 - 01/2002
6	Multiple Myeloma 04/2022 - 06/2011
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 08/2005
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2019
5	Residual Neoplasm 01/2012 - 06/2005
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2020
4	Cytokine Release Syndrome 12/2020 - 03/2004
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 08/2005
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2006
3	Infections 10/2020 - 02/2007
3	Hodgkin Disease (Hodgkin's Disease) 02/2017 - 10/2010
2	Disease Progression 10/2021 - 01/2019
2	Pathologic Complete Response 01/2021 - 01/2018
2	COVID-19 10/2020 - 01/2020
2	Inflammatory Breast Neoplasms 01/2017 - 08/2009
2	Bronchiolitis Obliterans Syndrome 01/2006 - 04/2005
1	Plasma Cell Neoplasms 04/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	cell-associated neurotoxicity 12/2020
1	Cardiomyopathies (Cardiomyopathy) 09/2020
1	Hypokalemia 01/2019
1	Sepsis (Septicemia) 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Thromboembolism 01/2019
1	Cardiotoxicity 01/2018
1	Fatigue 01/2018
1	Diarrhea 01/2018
1	Anorexia 01/2018
1	Nausea 01/2018
1	Vomiting 01/2018
1	Bacteremia 01/2018
1	Febrile Neutropenia 01/2018
1	Arthritis (Polyarthritis) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2015

Drug/Important Bio-Agent (IBA)

11	Chimeric Antigen ReceptorsIBA 01/2022 - 12/2018
7	AntigensIBA 12/2021 - 02/2004
6	tisagenlecleucelIBA 01/2022 - 01/2019
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 03/2003
5	fludarabineIBA 01/2018 - 03/2003
4	AnthracyclinesIBA 09/2020 - 05/2004
4	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 06/2005
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2011
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2006 - 03/2003
3	Monoclonal AntibodiesIBA 12/2013 - 05/2006
3	Biological ProductsIBA 06/2010 - 04/2005
2	brexucabtagene autoleucelIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2021 - 03/2008
2	SteroidsIBA 10/2020 - 01/2016
2	Rituximab (Mabthera)FDA Link 01/2019 - 03/2012
2	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 03/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 03/2003
2	Prednisone (Sone)FDA LinkGeneric 01/2019 - 03/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 02/2006
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 08/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2011
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 08/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 05/2004
2	Sirolimus (Rapamycin)FDA Link 10/2015 - 04/2013
2	Cancer VaccinesIBA 12/2013 - 06/2005
2	VaccinesIBA 12/2013 - 02/2004
2	Pharmaceutical PreparationsIBA 06/2010 - 11/2009
2	Etoposide (VP 16)FDA LinkGeneric 06/2005 - 03/2003
2	Trastuzumab (Herceptin)FDA Link 10/2004 - 04/2003
2	Taxoids (Taxanes)IBA 10/2004 - 05/2004
1	Indicators and Reagents (Reagents)IBA 12/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	Alemtuzumab (Campath)FDA Link 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	axicabtagene ciloleucelIBA 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	ElectrolytesIBA 01/2018
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2018
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018
1	Exportin 1 ProteinIBA 01/2018
1	selinexorIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	NivolumabIBA 01/2017
1	Pentostatin (Nipent)FDA LinkGeneric 10/2015
1	LigandsIBA 01/2015
1	AntibodiesIBA 01/2015

Therapy/Procedure

31	Hematopoietic Stem Cell Transplantation 01/2021 - 03/2003
26	Therapeutics 04/2022 - 04/2003
18	Stem Cell Transplantation 10/2021 - 02/2004
17	Drug Therapy (Chemotherapy) 10/2021 - 03/2003
11	Transplantation 01/2018 - 03/2003
8	Immunotherapy 12/2020 - 01/2002
6	Cell Transplantation 10/2020 - 02/2009
3	Homologous Transplantation 01/2019 - 11/2012
2	Aftercare (After-Treatment) 12/2013 - 10/2004
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2005 - 04/2005
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Remission Induction 01/2018